跳至主要内容
临床试验/NCT03309839
NCT03309839已完成不适用

HLA-DR Expression in Neonates After Cardiac Surgery Under Cardiopulmonary Bypass

Nantes University Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年1月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
HLA-DR expression

研究概览

简要总结

The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in neonates who underwent cardiac surgery with cardiopulmonary bypasss.

We hypothesize that HLA-DR expression in neonates is predictive of septic complications after cardiopulmonary bypass

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Patients aged ≤ 28 days
  • Admission after cardiac surgery under cardiopulmonary bypass

排除标准

  • Lack of parental consent

结局指标

主要结局

HLA-DR expression

时间窗: Preoperatively, and 1, 2, 3 and 4 days after the end of cardiopulmonary bypass

Number of HLA-DR molecules per monocyte (AB/c) determined by flow cytometry on whole blood using a Quantibrite phycoerythrin fluorescence quantitation kit (BD Biosciences) Number of HLA-DR molecules per monocyte (AB/c) determined by flow cytometry on whole blood using a Quantibrite phycoerythrin fluorescence quantitation kit (BD Biosciences)

次要结局

  • Cytokines measurements(Preoperatively, and 1, 2, 3 and 4 days after the end of cardiopulmonary bypass)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验